These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15693028)

  • 1. QALYs and the capability approach.
    Cookson R
    Health Econ; 2005 Aug; 14(8):817-29. PubMed ID: 15693028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capabilities as menus: a non-welfarist basis for QALY evaluation.
    Bleichrodt H; Quiggin J
    J Health Econ; 2013 Jan; 32(1):128-37. PubMed ID: 23202258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A utility-theoretic model for QALYs and willingness to pay.
    Klose T
    Health Econ; 2003 Jan; 12(1):17-31. PubMed ID: 12483758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New tests of QALYs when health varies over time.
    Bleichrodt H; Filko M
    J Health Econ; 2008 Sep; 27(5):1237-49. PubMed ID: 18644640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
    Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caring externalities in health economic evaluation: how are they related to severity of illness?
    Jacobsson F; Carstensen J; Borgquist L
    Health Policy; 2005 Aug; 73(2):172-82. PubMed ID: 15978960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of an economic model of health states worse than dead.
    Sharma R; Stano M
    J Health Econ; 2010 Jul; 29(4):536-40. PubMed ID: 20633775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality-adjusted life years was a poor predictor of women's willingness to pay in acute and chronic conditions: results of a survey.
    Franic DM; Pathak DS; Gafni A
    J Clin Epidemiol; 2005 Mar; 58(3):291-303. PubMed ID: 15718119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating chronic disease for heterogeneous populations: the case of arthritis.
    Scharff RL; Jessup A
    Med Care; 2007 Sep; 45(9):860-8. PubMed ID: 17712256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating preferences into health status assessment for amyotrophic lateral sclerosis: the ALS Utility Index.
    Beusterien K; Leigh N; Jackson C; Miller R; Mayo K; Revicki D
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Sep; 6(3):169-76. PubMed ID: 16183558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A note on the nature of utility in time and health and implications for cost utility analysis.
    Buckingham KJ; Devlin NJ
    Soc Sci Med; 2009 Jan; 68(2):362-7. PubMed ID: 19019518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality-adjusted life years: how useful in medico economic studies.
    Brauer CA; Neumann PJ
    Fundam Clin Pharmacol; 2005 Dec; 19(6):603-7. PubMed ID: 16313271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On future non-medical costs in economic evaluations.
    Liljas B; Karlsson GS; Stålhammar NO
    Health Econ; 2008 May; 17(5):579-91. PubMed ID: 17787027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longevity bias in cost-effectiveness analysis.
    Liu L; Rettenmaier AJ; Saving TR
    Health Econ; 2008 Apr; 17(4):523-34. PubMed ID: 17990284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cost-utility analysis of chronic spinal pain treatment outcomes: converting SF-36 data into quality-adjusted life years.
    Hatten AL; Gatchel RJ; Polatin PB; Stowell AW
    Clin J Pain; 2006 Oct; 22(8):700-11. PubMed ID: 16988566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Goals of care in advanced dementia: quality of life, dignity and comfort.
    Volicer L
    J Nutr Health Aging; 2007; 11(6):481. PubMed ID: 17985063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economic value of informal care: a study of informal caregivers' and patients' willingness to pay and willingness to accept for informal care.
    van den Berg B; Bleichrodt H; Eeckhoudt L
    Health Econ; 2005 Apr; 14(4):363-76. PubMed ID: 15744739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The OMERACT Initiative. Towards a reference approach to derive QALY for economic evaluations in rheumatology.
    Boonen A; Maetzel A; Drummond M; Suarez-Almazor M; Harrison M; Welch V; Tugwell PS
    J Rheumatol; 2009 Sep; 36(9):2045-9. PubMed ID: 19738211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capabilities and health.
    Anand P
    J Med Ethics; 2005 May; 31(5):299-303. PubMed ID: 15863692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.